In breast cancer, hypermethylation of BECN1, LC3B, and ATG5 is frequently observed in early‐stage tumors, resulting in reduced autophagic activity, accumulation of damaged organelles, genomic instability, and tumor initiation [27]. Here, MAP1LC3B is linked to breast carcinoma.